By Sebastien Boridy (McGill University, Montreal, Canada)
For close to 40 years, CRS has been devoted to spreading information and knowledge about the science and technology of controlled release. In light of this history, Inside Track has decided to highlight the work of longtime CRS members to commemorate their dedication to the society and its mission. It is therefore only fitting that we start this series with a member who has served CRS for over two decades: Dr. Hamid Ghandehari.
Dr. Ghandehari is currently a professor in the departments of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering at the University of Utah, U.S.A., and he is the director of the Utah Center for Nanomedicine, part of the Nano Institute of Utah, which he cofounded. Dr. Ghandehari’s group develops novel methods for controlled delivery of bioactive agents, mainly focusing on genetically engineered polymers for gene delivery, water-soluble polymers for targeted delivery, poly(amido amine) (PAMAM) dendrimers for oral delivery, and inorganic nanoconstructs for controlled chemical delivery.